IRDVSPRME• 6 Months (Normalized)
IRD vs PRME (Opus Genetics Inc. vs Prime Medicine Inc.)
Showing Closing Date Range from Mar, 20 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
IRD Performance $5.63
+28.25%
Opus Genetics Inc.
Normalized Baseline0.00%
PRME Performance $3.2
-9.23%
Prime Medicine Inc.
Normalized Baseline0.00%
Alpha Spread Margin IRD LEADS
+37.48%
IRD outperforming by 37.48%
IRDPRME
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
IRD PRME
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | IRD Price | IRD Gain (%) | PRME Price | PRME Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $5.63 | +28.25% | $3.20 | -9.23% | +37.48% |
| Sep 15, 2026 | $5.82 | +32.57% | $3.14 | -10.80% | +43.37% |
| Sep 14, 2026 | $5.97 | +35.99% | $3.18 | -9.66% | +45.65% |
| Sep 11, 2026 | $6.04 | +37.59% | $3.13 | -11.08% | +48.67% |
| Sep 10, 2026 | $6.07 | +38.27% | $3.35 | -4.83% | +43.10% |
| Sep 09, 2026 | $5.73 | +30.52% | $3.47 | -1.42% | +31.94% |
| Sep 08, 2026 | $4.34 | -1.14% | $3.56 | +1.14% | -2.28% |
| Sep 04, 2026 | $4.67 | +6.38% | $3.70 | +5.11% | +1.27% |
| Sep 03, 2026 | $4.60 | +4.78% | $3.71 | +5.40% | -0.62% |
| Sep 02, 2026 | $4.45 | +1.37% | $3.67 | +4.26% | -2.89% |
| Sep 01, 2026 | $3.83 | -12.76% | $3.57 | +1.42% | -14.18% |
| Aug 31, 2026 | $3.62 | -17.54% | $3.59 | +1.99% | -19.53% |
| Aug 28, 2026 | $3.69 | -15.95% | $3.61 | +2.56% | -18.51% |
| Aug 27, 2026 | $3.85 | -12.30% | $3.64 | +3.41% | -15.71% |
| Aug 26, 2026 | $3.80 | -13.44% | $3.58 | +1.70% | -15.14% |
Page 1 of 9